People who are dealing with nasal congestion are being advised to limit their use of nasal decongestant sprays to just seven days to avoid worsening their symptoms. Recent research has revealed that almost 60% of pharmacists believe that the public lacks awareness about the risks associated with prolonged use of these sprays.
Although decongestant sprays provide quick relief from congestion due to colds, allergies, and sinusitis, the Royal Pharmaceutical Society (RPS) has issued a warning that extended usage beyond a week can result in rebound congestion. This condition, known as rhinitis medicamentosa, can exacerbate symptoms, leading individuals to become dependent on the sprays for normal breathing.
A survey conducted by the RPS among 300 pharmacists indicated that 74% of them feel the need for clearer packaging instructions highlighting the seven-day restriction, as 59% believe people are not fully informed about the risks. Additionally, nearly two-thirds of pharmacists reported intervening when they suspected overuse of the sprays.
Professor Amira Guirguis, the chief scientist at the RPS, emphasized the importance of adhering to the recommended usage period, stating that prolonged use of nasal decongestant sprays can worsen congestion. She called for better labeling on the packaging to raise awareness of the seven-day limit and advised individuals to consult with their pharmacist if congestion persists beyond that timeframe.
The RPS encourages patients to carefully follow the instructions provided on nasal spray packaging and seek guidance from pharmacists if congestion persists beyond seven days. Meanwhile, a spokesperson for PAGB, the consumer healthcare association, expressed concerns about sensational reporting on nasal decongestant sprays, emphasizing the importance of patient safety and responsible self-care practices.